Boothbay Fund Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,400	Closed	-$75.7K	–	1419
2023 Q4	$75.7K	Buy	+13,400	New	+$75.7K	﹤0.01%	1303
2021 Q2	–	Sell	-12,026	Closed	-$445K	–	1695
2021 Q1	$445K	Sell	12,026 -4,178	-26%	-$155K	0.02%	808
2020 Q4	$537K	Buy	+16,204	New	+$537K	0.02%	596